Valuation : Sartorius AG

Market Cap 14.75B 17.14B 13.87B 12.67B 23.71B 1,618B 23.77B 164B 63.62B 830B 64.35B 62.95B 2,674B P/E 2026 *
62.2x
P/E 2027 * 48.9x
Enterprise Value 18.32B 21.29B 17.24B 15.75B 29.46B 2,010B 29.54B 204B 79.04B 1,031B 79.95B 78.21B 3,323B EV / Sales 2026 *
4.92x
EV / Sales 2027 * 4.42x
Free-Float
35.87%
Yield 2026 *
0.34%
Yield 2027 * 0.41%
1 day-3.31%
1 week-5.97%
Current month-4.42%
1 month+4.07%
3 months+0.17%
6 months+5.96%
Current year-5.24%
1 week 55.04
Extreme 55.035
58.5
1 month 52.93
Extreme 52.93
58.84
Current year 46.97
Extreme 46.97
62.15
1 year 45.1
Extreme 45.1
62.15
3 years 38.24
Extreme 38.235
83.59
5 years 38.24
Extreme 38.235
128.99
10 years 38.24
Extreme 38.235
128.99
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-29
Director of Finance/CFO 55 2024-03-31
Chief Operating Officer 70 2000-12-31
Director TitleAgeSince
Director/Board Member 62 2002-08-31
Chairman 69 2017-07-18
Director/Board Member 77 2011-11-28
Change 5-day change 1-year change 3-year change Capi.($)
-3.31%-5.97% - - 17.14B
-3.10%-6.43%+22.77%-34.89% 17.14B
+1.73%+0.74%-34.27%+56.78% 1.66B
+0.29%-5.22%-51.29%-82.59% 958M
+0.47%-2.95%-21.17%+16.47% 934M
-0.05%+0.05%+58.88%-3.84% 780M
+0.09%-0.27%-32.81%-47.72% 672M
+0.33%+9.28%-35.36%-43.39% 619M
-1.01%+4.67%-32.99%-31.35% 530M
+0.10%-6.34%+84.74%+48.01% 415M
Average -0.45%-1.08%-4.61%-13.61% 2.63B
Weighted average by Cap. -2.61%-4.65%+11.98%-26.39%

Financials

2026 *2027 *
Net sales 3.72B 4.32B 3.5B 3.2B 5.98B 408B 6B 41.37B 16.05B 209B 16.24B 15.88B 675B 4.08B 4.74B 3.84B 3.51B 6.56B 448B 6.58B 45.37B 17.6B 230B 17.81B 17.42B 740B
Net income 255M 297M 240M 219M 411M 28.02B 412M 2.84B 1.1B 14.38B 1.11B 1.09B 46.32B 328M 382M 309M 282M 528M 36.04B 529M 3.65B 1.42B 18.49B 1.43B 1.4B 59.56B
Net Debt 3.58B 4.15B 3.36B 3.07B 5.75B 392B 5.76B 39.75B 15.42B 201B 15.6B 15.26B 648B 3.27B 3.8B 3.08B 2.81B 5.26B 359B 5.27B 36.35B 14.11B 184B 14.27B 13.96B 593B
Logo Sartorius AG
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Employees
14,279
Date Price Change Volume
26-09-04 US$55.04 -3.31% 4,045
26-09-03 US$56.92 -0.11% 2,586
26-09-02 US$56.98 +0.13% 3,006
26-09-01 US$56.91 -1.16% 3,901
26-08-31 US$57.58 -1.62% 5,815
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
237.20EUR
Average target price
269.11EUR
Spread / Average Target
+13.45%

Quarterly revenue - Rate of surprise